{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:47:39Z","timestamp":1787168859156,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81625014"],"award-info":[{"award-number":["81625014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3082-0","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T10:37:00Z","timestamp":1524134220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates"],"prefix":"10.1186","volume":"18","author":[{"given":"Longyang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuorui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-4994","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"issue":"12","key":"3082_CR1","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17(12):e383\u201392.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"3082_CR2","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1038\/emi.2017.74","volume":"6","author":"PF Wu","year":"2017","unstructured":"Wu PF, Liu WL, Hsieh MH, et al. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients. Emerg Microbes Infect. 2017;6(10):e87.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"3082_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","volume":"43","author":"O Lortholary","year":"2017","unstructured":"Lortholary O, Renaudat C, Sitbon K, et al. The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med. 2017;43(5):652\u201362.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3082_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jac\/dkt330","volume":"69","author":"W Liu","year":"2014","unstructured":"Liu W, Tan J, Sun J, et al. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study. J Antimicrob Chemother. 2014;69(1):162\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"3082_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP. Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist. 2017;10:249\u201359.","journal-title":"Infect Drug Resist"},{"key":"3082_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12879-017-2573-8","volume":"17","author":"HT Ou","year":"2017","unstructured":"Ou HT, Lee TY, Chen YC, et al. Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC Infect Dis. 2017;17:481.","journal-title":"BMC Infect Dis"},{"key":"3082_CR7","first-page":"464","volume":"8","author":"X Fan","year":"2017","unstructured":"Fan X, Xiao M, Liao K, et al. Notable increasing trend in azole non-susceptible Candida tropicalis causing invasive candidiasis in China (August 2009 to July 2014): molecular epidemiology and clinical azole consumption. Front Microbiol. 2017;8:464.","journal-title":"Front Microbiol"},{"issue":"7","key":"3082_CR8","doi-asserted-by":"publisher","first-page":"e02496","DOI":"10.1128\/AAC.02496-16","volume":"61","author":"L You","year":"2017","unstructured":"You L, Qian W, Yang Q, et al. ERG11 gene mutations and MDR1 upregulation confer pan-azole resistance in Candida tropicalis causing disseminated candidiasis in an acute lymphoblastic leukemia patient on posaconazole prophylaxis. Antimicrob Agents Chemother. 2017;61(7):e02496\u201316.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3082_CR9","first-page":"988","volume":"72","author":"MI Xisto","year":"2017","unstructured":"Xisto MI, Caramalho RD, Rocha DA, et al. Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug? J Antimicrob Chemother. 2017;72(4):988\u201392.","journal-title":"J Antimicrob Chemother"},{"key":"3082_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mmcr.2016.02.001","volume":"11","author":"S \u00c1lvarez-P\u00e9rez","year":"2016","unstructured":"\u00c1lvarez-P\u00e9rez S, Garc\u00eda ME, Cutuli MT, et al. Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog. Med Mycol Case Rep. 2016;11:9\u201312.","journal-title":"Med Mycol Case Rep"},{"issue":"11","key":"3082_CR11","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s10096-017-3034-4","volume":"36","author":"Y Wang","year":"2017","unstructured":"Wang Y, Yang Q, Chen L, et al. Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study. Eur J Clin Microbiol Infect Dis. 2017;36(11):2117\u201326.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"3082_CR12","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1128\/AAC.44.6.1578-1584.2000","volume":"44","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F, Calabrese D, Sanglard D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000;44(6):1578\u201384.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3082_CR13","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/AAC.02652-15","volume":"60","author":"MJ Choi","year":"2016","unstructured":"Choi MJ, Won EJ, Shin JH, et al. Resistance mechanisms and clinical features of fluconazole-nonsusceptible Candida tropicalis isolates compared with fluconazole-less-susceptible isolates. Antimicrob Agents Chemother. 2016;60(6):3653\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3082_CR14","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C, Dong D, Yu B, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3082_CR15","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/JCM.00937-12","volume":"50","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA, Diekema DJ. Progress in antifungal susceptibility testing of Candida spp. by use of clinical and laboratory standards institute broth microdilution methods, 2010 to 2012. J Clin Microbiol. 2012;50(9):2846\u201356.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"3082_CR16","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1128\/JCM.43.11.5593-5600.2005","volume":"43","author":"A Tavanti","year":"2005","unstructured":"Tavanti A, Davidson AD, Johnson EM, et al. Multilocus sequence typing for differentiation of strains of Candida tropicalis. J Clin Microbiol. 2005;43(11):5593\u201360.","journal-title":"J Clin Microbiol"},{"issue":"11\u201312","key":"3082_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s11046-016-0050-3","volume":"181","author":"C Jiang","year":"2016","unstructured":"Jiang C, Ni Q, Dong D, et al. The role of UPC2 gene in azole-resistant Candida tropicalis. Mycopathologia. 2016;181(11\u201312):833\u20138.","journal-title":"Mycopathologia"},{"issue":"4","key":"3082_CR18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/jac\/dkx047","volume":"72","author":"B Chapman","year":"2017","unstructured":"Chapman B, Slavin M, Marriott D, et al. Changing epidemiology of candidaemia in Australia. J Antimicrob Chemother. 2017;72(4):1103\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"3082_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.diagmicrobio.2016.02.009","volume":"85","author":"M Castanheira","year":"2016","unstructured":"Castanheira M, Messer SA, Rhomberg PR, et al. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY antifungal surveillance program (2013). Diagn Microbiol Infect Dis. 2016;85(2):200\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"3082_CR20","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1128\/AAC.00477-13","volume":"57","author":"A Forastiero","year":"2013","unstructured":"Forastiero A, Mesa-Arango AC, Alastruey-Izquiredo A, et al. Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications. Antimicrob Agents Chemother. 2013;57(10):4769\u201381.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3\u20134","key":"3082_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11046-014-9831-8","volume":"179","author":"J Tan","year":"2015","unstructured":"Tan J, Zhang J, Chen W, et al. The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia. Mycopathologia. 2015;179(3\u20134):213\u20138.","journal-title":"Mycopathologia"},{"key":"3082_CR22","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, et al. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;7:2173.","journal-title":"Front Microbiol"},{"issue":"3","key":"3082_CR23","first-page":"254","volume":"75","author":"H-J Lo","year":"2017","unstructured":"Lo H-J, Tsai S-H, Chu W-L, et al. Fruits as the vehicle of drug resistant pathogenic yeasts. J Inf Secur. 2017;75(3):254\u201362.","journal-title":"J Inf Secur"},{"issue":"10","key":"3082_CR24","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1128\/AAC.00842-15","volume":"59","author":"J Branco","year":"2015","unstructured":"Branco J, Silva AP, Silva RM, et al. Fluconazole and voriconazole resistance in Candida parapsilosis is conferred by gain-of-function mutations in MRR1 transcription factor gene. Antimicrob Agents Chemother. 2015;59(10):6629\u201333.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3082-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3082-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:08:12Z","timestamp":1554836892000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3082-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3082"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3082-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this study, patient sampling and data collection were approved by the research ethics board at Peking University People\u2019s Hospital. Participants consent was not necessary as this study was retrospective and participants were anonymized.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"162"}}